Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2020 Oct 26

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Endocrinologica 2020 Oct 26

DOI: 10.23736/S0391-1977.20.03199-5

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Untargeted metabolomics analysis of serum and follicular fluid samples from women with polycystic ovary syndrome

Wan-Li XU 1, Guo-Yan LIU 2, Ning ZHANG 2, Jian REN 1, Xiu-Yang LI 1, Yu-Qiu LI 1, Yu CHEN 1, Jia-Yi LIU 1

1 Shandong University of Traditional Chinese Medicine, Jinan, China; 2 The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China


PDF


BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with well-established metabolic abnormalities. In the present study, untargeted metabolomics technology was applied to analyze the serum and follicular fluid samples from women with polycystic ovary syndrome and healthy controls using 1H nuclear magnetic resonance (NMR).
METHODS: 70 samples for PCOS analysis were collected in hospital of Shandong University of Traditional Chinese Medicine, NMR was used as analytical technology and multivariate analysis was applied to analyze metabolomics difference in PCOS and healthy controls.
RESULTS: Significant metabolic differences were found in both serum and follicular fluid samples with orthogonal partial least-squares discriminant analysis (OPLS-DA). Three discriminated metabolites (1-Methylhistidine, threonine and Citrate) in both serum and follicular fluid were altered in PCOS patients. Abnormal energy metabolism, lipid metabolism and amino acid metabolism were detected in PCOS patients. Furthermore, more significantly changed amino acids were discovered in follicular fluid samples.
CONCLUSIONS: Our findings would provide a resource for further investigations on metabolic disturbance in PCOS patients.


KEY WORDS: PCOS; Metabolomics; Metabolites; NMR

top of page